Business Description
Thalys Medical Technology Group Inc
ISIN : CNE1000030C3
Share Class Description:
SHSE:603716: ACompare
Compare
Traded in other countries / regions
603716.China IPO Date
2016-10-31Description
Thalys Medical Technology Inc is an early-stage medical intensive service provider. The company specializes in intensive marketing services for medical testing, agents for in vitro diagnostic products, and research and development, production and sales of autonomous in vitro diagnostic products. The majority of the revenue is earned from its in-service medical inspection intensive marketing and services.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.91 | |||||
| Debt-to-EBITDA | -10.59 | |||||
| Interest Coverage | 0.15 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.36 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.4 | |||||
| 3-Year FCF Growth Rate | -118.7 | |||||
| 3-Year Book Growth Rate | -1.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.73 | |||||
| 9-Day RSI | 32.37 | |||||
| 14-Day RSI | 36.11 | |||||
| 6-1 Month Momentum % | -9.52 | |||||
| 12-1 Month Momentum % | -3.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.69 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 0.19 | |||||
| Days Inventory | 99.22 | |||||
| Days Sales Outstanding | 306.81 | |||||
| Days Payable | 161.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 17.66 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.18 | |||||
| Operating Margin % | 0.6 | |||||
| Net Margin % | -7.38 | |||||
| FCF Margin % | -0.96 | |||||
| ROE % | -10.77 | |||||
| ROA % | -3.96 | |||||
| ROIC % | 0.43 | |||||
| ROC (Joel Greenblatt) % | -7.4 | |||||
| ROCE % | -5.51 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 22.71 | |||||
| PS Ratio | 0.59 | |||||
| PB Ratio | 0.93 | |||||
| Price-to-Tangible-Book | 1.07 | |||||
| Price-to-Free-Cash-Flow | 302.86 | |||||
| Price-to-Operating-Cash-Flow | 22.07 | |||||
| EV-to-EBIT | -19.02 | |||||
| EV-to-EBITDA | -19.02 | |||||
| EV-to-Revenue | 1.09 | |||||
| EV-to-FCF | -122.51 | |||||
| Price-to-Projected-FCF | 7.15 | |||||
| Price-to-Net-Current-Asset-Value | 3.18 | |||||
| Earnings Yield (Greenblatt) % | -5.26 | |||||
| FCF Yield % | -1.55 | |||||
| Forward Rate of Return (Yacktman) % | -27.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thalys Medical Technology Group Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,075.613 | ||
| EPS (TTM) (Â¥) | -0.749 | ||
| Beta | 0.58 | ||
| Volatility % | 35.95 | ||
| 14-Day RSI | 36.11 | ||
| 14-Day ATR (Â¥) | 0.485984 | ||
| 20-Day SMA (Â¥) | 7.739 | ||
| 12-1 Month Momentum % | -3.58 | ||
| 52-Week Range (Â¥) | 5.2 - 15.98 | ||
| Shares Outstanding (Mil) | 201.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thalys Medical Technology Group Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thalys Medical Technology Group Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Thalys Medical Technology Group Inc Frequently Asked Questions
What is Thalys Medical Technology Group Inc(SHSE:603716)'s stock price today?
The current price of SHSE:603716 is ¥6.36. The 52 week high of SHSE:603716 is ¥15.98 and 52 week low is ¥5.20.
When is next earnings date of Thalys Medical Technology Group Inc(SHSE:603716)?
The next earnings date of Thalys Medical Technology Group Inc(SHSE:603716) is .
Does Thalys Medical Technology Group Inc(SHSE:603716) pay dividends? If so, how much?
Thalys Medical Technology Group Inc(SHSE:603716) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers